(617) 965-2681 Schedule a consultation

Glympse Bio

Creating an effective
investor outreach solution

Client: Glympse Bio

Category: Biotechnology

Customers: Investors, Scientific collaborators

Locations: Massachusetts, USA

Biotech innovator Glympse Bio developed a novel, non-invasive diagnostic biosensor technology with a primary focus on a specific liver disease. The company needed a new website to support its outreach to investors to fully realize Glympse’s market potential. RainCastle moved quickly to create an investor-ready online experience.

  • Website Copywriting
  • Website Design and Development
  • Investor Presentation Template

Bold Brand Message

Glympse wanted a strong hero image and message that communicates the exciting potential of its technology, which unlocks a wealth of information from a single blood sample. Our team delivered an impactful solution, combining an arresting image with copy that concisely conveys the immense potential for diagnosing and monitoring disease.

Our Solution

Website Design

The client felt its previous website design was cluttered, making it hard to digest information. We created a design that is clean, elegant and minimalist, with a logical flow of content and plenty of white space.

View

Website Editing

Our copywriter reviewed and edited copy provided by the client to ensure it was web-friendly and appropriate for both scientific and non-scientific investor audiences.

View

Content Creation

Our design team created a library of custom icons leveraging Glympse’s brand colors to complement key concepts and augment the website design. These icons can be used across the company’s marketing materials.

View

Investor Presentation

We carried over the visual language to Glympse’s investor PowerPoint deck. Our design team created a versatile template that maintains the clean, uncluttered look of the website.

View

Outcome

Company leadership was thrilled with the new website and slide deck, feeling they were well equipped to pursue investor and partnership opportunities. Ultimately, Glympse Bio merged with Sunbird Bio, providing the combined organization with expanded resources, capabilities and product pipeline.